Your session is about to expire
← Back to Search
[68Ga]CBP8 PET Imaging for Idiopathic Pulmonary Fibrosis
Study Summary
This trial will study if a new imaging agent is safe for use in patients with pulmonary fibrosis and if it can help detect collagen deposition.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I do not have any metal implants, fragments, or metallic tattoos.My kidney function is low, with an eGFR under 30.You have a pacemaker or other electrical device implanted in your body.Your body mass index (BMI) is higher than 33, which is the limit for the MRI table.I have a lung condition, but not fibrosis, or had recent lung infections or chest radiation.I haven't had pneumonia or a serious lung infection in the last 6 weeks.I am over 18 years old and healthy.If you are in the healthy group, you have never used tobacco before.I am not pregnant or breastfeeding, and I have a negative pregnancy test.I cannot lie comfortably in an MR-PET machine.I have stage IIIA NSCLC and am a candidate for combined treatment including surgery.I have a type of lung scarring known as pulmonary fibrosis or another similar lung condition.I am over 18 and have lung cancer.You have had too much radiation exposure from medical tests in the past year.I have pulmonary fibrosis and haven't used tobacco in the last 6 months.I have lung cancer and haven't used tobacco in the last 6 months.I am between 40 and 80 years old with pulmonary fibrosis.I can sign and understand the consent form for the study.I am healthy and have no history of lung diseases.I experience severe discomfort in confined spaces.
- Group 1: Healthy Individuals
- Group 2: Lung Cancer Subjects
- Group 3: Pulmonary Fibrosis Subjects
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the study open to participants who are of advanced age?
"This medical research is available to adults who are over the age of 18 and under 80 years old."
Is there any risk of harm posed by PET scanning procedures?
"Our appraisal of PET Imaging's safety is a 1, as it is currently going through the first phase of clinical trials and has little supporting data concerning its efficacy."
What is the current intake rate for participants of this experiment?
"Indeed, clinicaltrials.gov reveals that this medical trial is actively recruiting. It was initially posted on August 1st 2018 and the most recent update occurred on June 13th 2022. The research requires 100 individuals to be enrolled across one site."
Is this trial actively seeking participants at the moment?
"Affirmative. Per the information hosted on clinicaltrials.gov, this medical trial is recruiting patients and was first posted on August 1st 2018. The most recent update was made June 13th 2022 and it requires 100 individuals from one location to participate."
Which individuals are eligible to join this investigation?
"To qualify for this research trial, applicants must have a diagnosis of pulmonary fibrosis and be between 18-80 years old. Approximately 100 participants are being accepted."
Share this study with friends
Copy Link
Messenger